細胞化驗分析市場：按檢測類型、應用、最終用戶和地區分類。

2026年，細胞化驗分析市場規模估計為76億美元，預計到2033年將達到164.8億美元。預計從2026年到2033年，該市場將以11.7%的複合年成長率成長。

全球細胞化驗分析市場涵蓋多種產品，包括細胞活力檢測、細胞毒性檢測、增殖檢測及其他類似檢測類型。這些檢測方法廣泛應用於藥物研發、毒性測試和疾病建模，並被製藥和生物技術公司以及學術和研究機構廣泛採用。隨著各機構日益重視檢測的效能、效率和成本效益，這些領域的應用也持續穩定成長。

市場動態：

來自製藥和生物技術公司以及學術和研究機構的需求不斷成長，對更高效率和可靠性的需求不斷提高，以及持續的產品創新，預計將是推動全球細胞化驗分析市場成長的主要因素。藥物發現和毒性測試領域應用範圍的不斷擴大，進一步加速了這一成長動能。

例如，市場參與者正在實施專為藥物研發應用場景設計的先進解決方案。此外，預計在預測期內，持續的技術進步和策略投資將為市場參與者創造新的成長機會。

本報告的主要特點

• 本報告揭示了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
• 此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
• 本節根據公司概況、產品系列、主要趨勢、財務表現和策略等各種參數，對全球細胞化驗分析市場的主要公司進行介紹。
• 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術更新、市場擴張和行銷策略做出明智的決策。
• 《全球細胞化驗分析市場》報告面向該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
• 相關人員可以透過分析全球細胞化驗分析市場中使用的各種策略矩陣來促進決策。

目錄

第1章：分析目標與假設

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
  • 抑制因子
  • 市場機遇
• 影響分析
• 近期產品發布
• 流行病學
• 企業合併、商業合作
• 監管趨勢
• 主要進展
• PEST分析
• 商業夥伴關係場景
• 品牌和定價分析
• 銷售代理情況
• 波特五力分析
• 技術進步
• 主要進展
• 市場趨勢
• 前景
• 主要公司：按銷售收入

第4章：細胞化驗分析市場：按檢測類型分類（2026-2033 年）

• 存活率測定
• 細胞毒性試驗
• 生長測定
• 報導基因分析
• 其他

第5章：細胞化驗分析市場：按應用領域分類（2026-2033 年）

• 藥物發現
• 毒性測試
• 疾病建模
• 幹細胞研究
• 其他

第6章：細胞化驗分析市場：按最終用戶分類（2026-2033 年）

• 製藥和生物技術公司
• 學術和研究機構
• CRO（委外研發機構）
• 其他

第7章：細胞化驗分析市場：按地區分類（2026-2033 年）

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲國家
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 比荷盧經濟聯盟
  • 丹麥
  • 挪威
  • 瑞典
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 台灣
  • 印度
  • 日本
  • 印尼
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 澳洲
  • 韓國
  • 其他亞太國家
• 中東和非洲
  • 巴林
  • 科威特
  • 阿曼
  • 卡達
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 北非
  • 中非
  • 其他中東國家

第8章 競爭情勢

• Thermo Fisher Scientific
• Merck KGaA
• PerkinElmer Inc.
• Bio-Rad Laboratories
• Danaher Corporation
• Agilent Technologies
• Lonza Group
• GE Healthcare
• Biocompare
• Promega Corporation
• Sartorius AG
• Cell Signaling Technology

第9章

• 分析方法
• 關於 Coherent Market Insights

Cell-Based Assay Market is estimated to be valued at USD 7.60 billion in 2026 and is expected to reach USD 16.48 billion by 2033, growing at a compound annual growth rate (CAGR) of 11.7% from 2026 to 2033.

The global cell-based assay market includes offerings that span Viability Assays, Cytotoxicity Assays, and Proliferation Assays, and similar assay type categories. These are applied across Drug Discovery, Toxicity Testing, and Disease Modeling and adopted by Pharmaceutical & Biotechnology Companies, and Academic & Research Institutes. As organizations increasingly prioritize performance, efficiency, and cost-effectiveness, adoption across these segments continues to grow steadily.

Market Dynamics:

Increasing demand from Pharmaceutical & Biotechnology Companies, and Academic & Research Institutes, the need for improved efficiency and reliability, and ongoing product innovation are major factors expected to drive growth of the global cell-based assay market. Broader adoption across Drug Discovery, and Toxicity Testing is reinforcing this momentum.

For instance, market players are introducing advanced solutions designed for Drug Discovery use cases. Moreover, continued technological advancement and strategic investment are expected to create new growth opportunities for market players over the forecast period.

Key features of the study:

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global cell-based assay market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Thermo Fisher Scientific, Merck KGaA, PerkinElmer Inc., Bio-Rad Laboratories, Danaher Corporation, Agilent Technologies, Lonza Group, GE Healthcare, Biocompare, Promega Corporation, Sartorius AG, and Cell Signaling Technology, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global cell-based assay market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell-based assay market.

Detailed Segmentation:

• Global Cell-Based Assay Market, By Assay Type (Revenue, USD Bn, 2021 - 2033)
• Viability Assays
• Cytotoxicity Assays
• Proliferation Assays
• Reporter Gene Assays
• Others
• Global Cell-Based Assay Market, By Application (Revenue, USD Bn, 2021 - 2033)
• Drug Discovery
• Toxicity Testing
• Disease Modeling
• Stem Cell Research
• Others
• Global Cell-Based Assay Market, By End User (Revenue, USD Bn, 2021 - 2033)
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations (CROs)
• Others
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Company Profiles:
• Thermo Fisher Scientific*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
• Merck KGaA
• PerkinElmer Inc.
• Bio-Rad Laboratories
• Danaher Corporation
• Agilent Technologies
• Lonza Group
• GE Healthcare
• Biocompare
• Promega Corporation
• Sartorius AG
• Cell Signaling Technology

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Preview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Assay Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Recent Product Launches
• Epidemiology
• Merger, Acquisition, and Collaborations
• Regulatory Scenario
• Key Developments
• PEST Analysis
• Partnership Scenario
• Brand and Pricing Analysis
• Distributors Landscape
• Porters Analysis
• Technological Advancements
• Key Developments
• Market Trend
• Future Prospective
• Top Market Players by Revenue

4. Cell-Based Assay Market, By Assay Type, 2026-2033, (US$ Billion)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segment Trends
• Viability Assays
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
• Cytotoxicity Assays
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
• Proliferation Assays
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
• Reporter Gene Assays
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

5. Cell-Based Assay Market, By Application, 2026 - 2033, (US$ Billion)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segment Trends
• Drug Discovery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
• Toxicity Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
• Disease Modeling
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
• Stem Cell Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

6. Cell-Based Assay Market, By End User, 2026 - 2033, (US$ Billion)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segment Trends
• Pharmaceutical & Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
• Academic & Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
• Contract Research Organizations (CROs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

7. Cell-Based Assay Market, By Region, 2026 - 2033, (US$ Billion)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Regions, 2022-2033
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Benelux
    • Denmark
    • Norway
    • Sweden
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
    • China
    • Taiwan
    • India
    • Japan
    • Indonesia
    • Malaysia
    • Philippines
    • Singapore
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
    • Bahrain
    • Kuwait
    • Oman
    • Qatar
    • Saudi Arabia
    • UAE
    • Israel
    • South Africa
    • North Africa
    • Central Africa
    • Rest of Middle East

8. Competitive Landscape

• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• PerkinElmer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Bio-Rad Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Danaher Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Agilent Technologies
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Lonza Group
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Biocompare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Promega Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Sartorius AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Cell Signaling Technology
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

9. Section

• Research Methodology
• About Us